| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
BML, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥16.70 |
| 52 Week High | JP¥19.10 |
| 52 Week Low | JP¥15.60 |
| Beta | 0.31 |
| 11 Month Change | 4.38% |
| 3 Month Change | -5.11% |
| 1 Year Change | -4.57% |
| 33 Year Change | -42.37% |
| 5 Year Change | -32.66% |
| Change since IPO | -15.44% |
Recent News & Updates
Recent updates
Shareholder Returns
| BMZ | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 1.8% | 1.1% | 0.8% |
| 1Y | -4.6% | 2.7% | 6.1% |
Return vs Industry: BMZ underperformed the German Healthcare industry which returned 2.7% over the past year.
Return vs Market: BMZ underperformed the German Market which returned 6.1% over the past year.
Price Volatility
| BMZ volatility | |
|---|---|
| BMZ Average Weekly Movement | 3.6% |
| Healthcare Industry Average Movement | 5.3% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in DE Market | 10.5% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: BMZ has not had significant price volatility in the past 3 months.
Volatility Over Time: BMZ's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1955 | 4,513 | Kensuke Kondo | www.bml.co.jp |
BML, Inc. provides laboratory testing and related services in Japan. The company offers a range of laboratory testing, such as biochemical and hematologic examination; special laboratory test, including RIA, cellular, immunological, and DNA analysis; and microbiological tests for medical and pharmaceutical societies and organizations; laboratory tests in tumorology, infectious disease, diabetes, hypertension, allergy, and genetic studies, as well as develops Frontier and Symphony automation systems, which automate pre-processing procedures from sorting to dispensing, and subsequent test procedures. It also provides medical information system services, which include electronic medical charts for networking medical information, as well as preventive medicine services.
BML, Inc. Fundamentals Summary
| BMZ fundamental statistics | |
|---|---|
| Market cap | €654.30m |
| Earnings (TTM) | €34.62m |
| Revenue (TTM) | €791.64m |
18.9x
P/E Ratio0.8x
P/S RatioIs BMZ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BMZ income statement (TTM) | |
|---|---|
| Revenue | JP¥137.96b |
| Cost of Revenue | JP¥92.34b |
| Gross Profit | JP¥45.63b |
| Other Expenses | JP¥39.60b |
| Earnings | JP¥6.03b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 09, 2024
| Earnings per share (EPS) | 154.78 |
| Gross Margin | 33.07% |
| Net Profit Margin | 4.37% |
| Debt/Equity Ratio | 0% |
How did BMZ perform over the long term?
See historical performance and comparison